IFNA1 and neoplasm: However, combining IL-12 and IFNα with TAA delivery led to improved anti-tumor immunity compared to cytokines alone, highlighting the importance of exogenous TA delivery for robust presentation which, in the presence of immune activating cytokines, may effectively activate T cells with lower affinity for the TA or present at very low frequency.